Shopping Cart (0)
My Account

Your Shopping Cart
Molecular Medicine Congress

Molecular Medicine Congress



Welcome to Molecular Medicine Congress and exhibition. 

There is lots of excitement in this field regarding the creation and development of new tools for improving the detection, diagnosis and treatment of diseases at the molecular level. This conference will discuss the expression patterns of proteomes and use them to differentiate between what is normal and abnormal. There will be particular focus on point-of-care diagnostics, predictive biomarkers and their discovery and detection. Additionally, the cutting-edge subjects of circulating tumour cells and diagnostic applications of exosomes will be explored, giving delegates a brilliant insight into this rapidly expanding field. 

Molecular Medicine Congress will provide the latest novel applications in molecular mechanisms and therapeutic developments. It will also offer new ideas and approaches for research and offer the opportunity for scientists to collaborate with the experts in this field. Our panel of distinguished speakers will present their recent discoveries and most updated scientific information, which will make for a very exciting and rewarding conference to attend.

Our Molecular Medicine Congress 2013 is an international event being hosted in beautiful city of Frankfurt, Germany.

Molecular Medicine Congress Video


Keynote Speakers

Till Bachmann

Till Bachmann
Reader/Chief Operating Officer, University of Edinburgh

Sudhir Kumar

Sudhir Kumar
Professor, Arizona State University

Klaus Pantel

Klaus Pantel
Director, University Medical Center Hamburg Eppendorf

Lawrence Rajendran

Lawrence Rajendran
Professor, University of Zurich

Agenda Topics

  • Applications of Exosomes and Microvesicles
    • Biology and Role in Intercellular Communication
    • Biomarkers/Diagnostics
    • Cancer and Other Diseases
    • Characterisation of Cellular Vesicles
    • microRNAs and Proteins in Exosomes
    • Therapeutic Applications
  • Applications of Sequencing Data
  • Cancer Personalised Medicine
  • Companion Diagnostics
  • Data Analysis and Bioinformatics
  • Disease Related Biomarkers
    • Biomarker Classes: Genomics-based, Proteomics-based, Metabolomics-based
    • Discovery & Validation Technologies
    • Gene Signatures for Breast and Colon Cancers: Drivers of Innovation in this Field
    • Predictive vs. Prognostic Biomarkers
  • Emerging Technologies in MDx and CDx
  • Sequencing in Rapid Disease Diagnosis

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44(0)1787 315110

Confirmed Speakers to date

Stephen Pennington, Professor, University College Dublin
Enal Razvi, Managing Director, Select Biosciences, Inc.
Mike Makrigiorgos, Professor, Dana-Farber Cancer Institute/Harvard Medical School
William Gallagher, Associate Professor, University College Dublin
Evi Lianidou, Professor, University of Athens
Sofia Dembski, Researcher, Fraunhofer Institute for Silicate Research
Gloria Alvarez-Llamas, Senior Investigator, IIS-Fundacion Jimenez Diaz
Michiel Pegtel, Assistant Professor, VU University Amsterdam
Tanja Fehm, Professor, University of Tuebingen
Catherine Alix-Panabières, Associate Professor, University Medical Center of Montpellier
Jonathan O'Halloran, Group CSO & Co-founder, QuantuMDx Group Ltd
Muthuvel Jayachandran, Associate Professor, Mayo Clinic
Raymond Schiffelers, Associate Professor, University Medical Center Utrecht
Paul Robbins, Professor, Scripps Research Institute
Hong Sun, Assistant Professor , NYU School of Medicine
Thomas Benen, Application Specialist, Nanosight
Robert Loewe, CEO, Genewake


Exhibition Sponsors Media Sponsors Networking
U-Networks




There is currently no news for this conference.
    Keep me updated Select Bio Blog Linked in Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com